Diabetes is an endocrine disorder which is known by abnormal high blood glucose levels. There are two main categories of diabetes: type I (10%–15%) and type II (85%–90%). Although type II is more common, type I is the most common form in children. Diabetic retinopathy (DR), which remains the foremost cause of losing vision in working-age populations, can be considered as the main complication of diabetes mellitus. So choosing the best method for diagnosing, tracking, and treating the DR is vital to enhance the quality of life and decrease the medical expenses. Each method for diagnosing DR has some advantages and the best way must be selected according to the points that we need to find. For writing this manuscript, we made a list of relevant keywords including diabetes, DR, pathophysiology, ultrawide field imaging, fluorescein angiography, optical coherence tomography, and optical coherence tomography-angiography, and then we started searching for studies in PubMed, Scopus, and Web of Science databases. This review article covers the pathophysiology of DR and medical imaging techniques to monitor DR. First, we introduce DR and its pathophysiology and then we present the medical imaging techniques to monitor it.
BafadamSBeheshtiFKhodabakhshiT, et al. Trigonella foenum-graceum seed (Fenugreek) hydroalcoholic extract improved the oxidative stress status in a rat model of diabetes-induced memory impairment. Horm Mol Biol Clin Invest2019; 39(2): 1–13.
2.
Diaz-ValenciaPABougnèresPValleronA-J. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health2015; 15(1): 1–15.
3.
EbrahimiBAziziHSarkariziHK, et al. Comparing the effect of electroacupuncture and glibenclamide on blood glucose level and histological markers of pancreas in streptozotocin-induced diabetic rats. Altern Ther Health Med2020; 26(S2): 12–19.
4.
EbrahimiBEstajiMRajabzadehA. The effect of different doses of glibenclamide on blood glucose and islet volume in diabetic rats. Navid No2019; 21(68): 10–18.
5.
GroupTS. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med2012; 366(24): 2247–2256.
6.
ZhouBLuYHajifathalianK, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet2016; 387(10027): 1513–1530.
7.
VosTAllenCAroraM, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet2016; 388(10053): 1545–1602.
8.
SeuringTArchangelidiOSuhrckeM. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics2015; 33(8): 811–831.
9.
DeFronzoRA. From the triumvirate to the “ominous octet”: a new paradigm for the treatment of type 2 diabetes mellitus. Clin Diabetol2009; 10(3): 101–128.
10.
EbrahimiBForouzanfarFAziziH, et al. Effect of electroacupuncture and glibenclamide on blood glucose level and oxidative stress parameters in streptozotocin-induced diabetic rats and possible human implications. Acupuncture Electro-Ther Res2020; 44(3–4): 213–228.
11.
WangWLoAC. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci2018; 19(6): 1816.
12.
ZhangXSaaddineJBChouC-F, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA2010; 304(6): 649–656.
13.
Romero-ArocaPBaget-BernaldizMPareja-RiosA, et al. Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res2016; 2016: 2156273.
14.
Simó-ServatOHernándezCSimóR. Diabetic retinopathy in the context of patients with diabetes. Ophthalmic Res2019; 62(4): 211–217.
15.
RodríguezMLPérezSMena-MolláS, et al. Oxidative stress and microvascular alterations in diabetic retinopathy: future therapies. Oxid Med Cell Longevity2019; 2019: 4940825.
16.
WuLFernandez-LoaizaPSaumaJ, et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes2013; 4(6): 290.
17.
VermaKDeepPRamakrishnanA (eds). Detection and classification of diabetic retinopathy using retinal images. In: 2011 Annual IEEE India conference, 2011. New York: IEEE.
18.
BrownleeM. The pathobiology of diabetic complications: a unifying mechanism. Diabetes2005; 54(6): 1615–1625.
19.
GiaccoFBrownleeM. Oxidative stress and diabetic complications. Circ Res2010; 107(9): 1058–1070.
20.
KusuharaSFukushimaYOguraS, et al. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J2018; 42(5): 364.
21.
BekT. Diameter changes of retinal vessels in diabetic retinopathy. Curr Diabetes Rep2017; 17(10): 1–7.
22.
NaruseKNakamuraJHamadaY, et al. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exper Eye Res2000; 71(3): 309–315.
23.
RomeoGLiuW-HAsnaghiV, et al. Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes2002; 51(7): 2241–2248.
24.
EjazSChekarovaIEjazA, et al. Importance of pericytes and mechanisms of pericyte loss during diabetic retinopathy. Diabetes Obes Metab2008; 10(1): 53–63.
25.
BeltramoEPortaM. Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr med Chem2013; 20(26): 3218–325.
26.
HuangHHeJWeiY, et al. Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition. Diabetes2015; 64(1): 200–212.
27.
LupoGMottaCGiurdanellaG, et al. Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. Biochem Pharmacol2013; 86(11): 1603–1613.
28.
AntonettiDABarberAJHollingerLA, et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1 A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem1999; 274(33): 23463–23467.
29.
RousseauSHouleFLandryJ, et al. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene1997; 15(18): 2169–2177.
30.
SunJKLinMMLammerJ, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol2014; 132(11): 1309–1316.
31.
JialalIKaurH. The role of toll-like receptors in diabetes-induced inflammation: implications for vascular complications. Curr Diabetes Rep2012; 12(2): 172–179.
32.
RübsamAParikhSFortPE. Role of inflammation in diabetic retinopathy. Int J Mol Sci2018; 19(4): 942.
33.
MiyamotoKKhosrofSBursellS-E, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA1999; 96(19): 10836–1041.
34.
YuukiTKandaTKimuraY, et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications2001; 15(5): 257–259.
35.
SchröderSPalinskiWSchmid-SchönbeinG. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol1991; 139(1): 81.
36.
JoussenAMPoulakiVMitsiadesN, et al. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood–retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J2003; 17(1): 76–78.
37.
BarouchFCMiyamotoKAllportJR, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Investig Ophthalmol Visual Sci2000; 41(5): 1153–1158.
38.
KaszaMMelegJVárdaiJ, et al. Plasma E-selectin levels can play a role in the development of diabetic retinopathy. Graefe’s Arch ClinExper Ophthalmol2017; 255(1): 25–30.
39.
SuzukiYNakazawaMSuzukiK, et al. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol2011; 55(3): 256–263.
40.
RangasamySMcGuirePGNittaCF, et al. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood–retinal barrier in diabetic retinopathy. PLoS One2014; 9(10): e108508.
SorrentinoFSAllkabesMSalsiniG, et al. The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy. Life Sci2016; 162: 54–59.
43.
El-AsrarAMADralandsLMissottenL, et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. Investig Ophthalmol Visual Sci2004; 45(8): 2760–2766.
44.
KowluruRAKoppoluP. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radical Res2002; 36(9): 993–999.
45.
TienTZhangJMutoT, et al. High glucose induces mitochondrial dysfunction in retinal Müller cells: implications for diabetic retinopathy. Investig ophthalmol Visual Sci2017; 58(7): 2915–2921.
46.
SasakiMOzawaYKuriharaT, et al. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia2010; 53(5): 971–979.
47.
BattistaMBorrelliESacconiR, et al. Optical coherence tomography angiography in diabetes: a review. Eur J Ophthalmol2020; 30(3): 411–416.
48.
MarkanAAgarwalAAroraA, et al. Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema. Ther Adv Ophthalmol2020; 12: 2515841420950513.
49.
VujosevicSAldingtonSJSilvaP, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol2020; 8(4): 337–347.
50.
FurtadoWShalabyAMahmoudAH, et al. A noninvasive approach for the early detection of diabetic retinopathy. Diabetes Retinopathy2020; 2: 205–228.
51.
HaraTInamiMHaraT. Efficacy and safety of fluorescein angiography with orally administered sodium fluorescein. Am J Ophthalmol1998; 126(4): 560–564.
52.
ChuaJSimRTanB, et al. Optical coherence tomography angiography in diabetes and diabetic retinopathy. J Clin Med2020; 9(6): 1723.
53.
FalavarjaniKGTsuiISaddaSR. Ultra-wide-field imaging in diabetic retinopathy. Vision Res2017; 139: 187–190.
54.
SunZYangDTangZ, et al. Optical coherence tomography angiography in diabetic retinopathy: an updated review. Eye2020: 35(1): 149–161.
55.
SpaideRFKlancnikJMCooneyMJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol2015; 133(1): 45–50.
56.
MendisKRBalaratnasingamCYuP, et al. Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail. Investig Ophthalmol Visual Sci2010; 51(11): 5864–5869.
57.
SchwartzRKhalidHSivaprasadS, et al. Objective evaluation of proliferative diabetic retinopathy using OCT. Ophthalmol Retina2020; 4(2): 164–174.
58.
WilliamsGAScottIUHallerJA, et al. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology2004; 111(5): 1055–1062.
59.
LambertM. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Internal Med1996; 125(11): 939.
60.
SrinivasanVWojtkowskiMFujimotoJ, et al. In vivo measurement of retinal physiology with high-speed ultrahigh-resolution optical coherence tomography. Optics Lett2006; 31(15): 2308–2310.
61.
BaumannBPotsaidBKrausMF, et al. Total retinal blood flow measurement with ultrahigh speed swept source/Fourier domain OCT. Biomed Optics Express2011; 2(6): 1539–1552.
62.
LeitgebRASchmettererLDrexlerW, et al. Real-time assessment of retinal blood flow with ultrafast acquisition by color Doppler Fourier domain optical coherence tomography. Opt Express2003; 11(23): 3116–3121.
63.
PovažayBBizhevaKHermannB, et al. Enhanced visualization of choroidal vessels using ultrahigh resolution ophthalmic OCT at 1050 nm. Opt Express2003; 11(17): 1980–1986.
64.
JiaYBaileySTWilsonDJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology2014; 121(7): 1435–1444.
65.
VermeerKMoJWedaJ, et al. Depth-resolved model-based reconstruction of attenuation coefficients in optical coherence tomography. Biomed Opt Express2014; 5(1): 322–337.
66.
GhazalMAl KhalilYAlhalabiM, et al. Early detection of diabetics using retinal OCT images. Diabetes Retinopathy2020; 2: 173–204.
67.
BuAbbudJCAl-latayfehMMSunJK. Optical coherence tomography imaging for diabetic retinopathy and macular edema. Curr Diabet Rep2010; 10(4): 264–269.
68.
StaurenghiGSaddaSChakravarthyU, et al. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN•OCT consensus. Ophthalmology2014; 121(8): 1572–1578.
69.
SpaideRFCurcioCA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina2011; 31(8): 1609.
70.
StolteSFangR. A survey on medical image analysis in diabetic retinopathy. Med image Anal2020; 64: 101742.
71.
LeeJMoonBGChoAR, et al. Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response. Ophthalmology2016; 123(11): 2368–2375.
72.
TotoLD’AloisioRDi NicolaM, et al. Qualitative and quantitative assessment of vascular changes in diabetic macular edema after dexamethasone implant using optical coherence tomography angiography. Int J Mol Sci2017; 18(6): 1181.
73.
de CarloTEChinATJosephT, et al. Distinguishing diabetic macular edema from capillary nonperfusion using optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina2016; 47(2): 108–114.
74.
SilvaPSCruzAJDLedesmaMG, et al. Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography. Ophthalmology2015; 122(12): 2465–2472.
75.
LiewGSimDAKeanePA, et al. Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes. Acta Ophthalmologica2015; 93(1): e45–e51.
76.
ChhablaniJSharmaAGoudA, et al. Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography. Investig Ophthalmol Visual Sci2015; 56(11): 6333–6338.
77.
TakaseNNozakiMKatoA, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina2015; 35(11): 2377–2383.
78.
SilvaPSHortonMBClaryD, et al. Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program. Ophthalmology2016; 123(6): 1360–1367.
79.
DhasmanaRSahSGuptaN. Study of retinal nerve fibre layer thickness in patients with diabetes mellitus using Fourier domain optical coherence tomography. J Clin Diagn Res2016; 10(7): NC05.
80.
StemMDunbarGJacksonG, et al. Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus. Eye2016; 30(6): 825–832.
81.
ZahidSDolz-MarcoRFreundKB, et al. Fractal dimensional analysis of optical coherence tomography angiography in eyes with diabetic retinopathy. Investig Ophthalmol Visual Sci2016; 57(11): 4940–4947.
82.
GarciaJMBdBLimaTTLouzadaRN, et al. Diabetic macular ischemia diagnosis: comparison between optical coherence tomography angiography and fluorescein angiography. J Ophthalmol2016; 2016: 3989310.
83.
RasquinhaABappalAArunachalamC. Fundus fluorescein angiography in diabetic retinopathy: correlation of angiographic findings to the clinical maculopathy. IOSR J Dental Med Sci (IOSR-JDMS)2016; 15(2): 80–88.
84.
LinADLeeAYZhangQ, et al. Association between OCT-based microangiography perfusion indices and diabetic retinopathy severity. Br J Ophthalmol2017; 101(7): 960–964.
85.
SoaresMNevesCMarquesIP, et al. Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol2017; 101(1): 62–68.
86.
ShenZ-JYangX-FXuJ, et al. Association of choroidal thickness with early stages of diabetic retinopathy in type 2 diabetes. Int J Ophthalmol2017; 10(4): 613.
87.
NeriyanuriSPardhanSGellaL, et al. Retinal sensitivity changes associated with diabetic neuropathy in the absence of diabetic retinopathy. Br J Ophthalmol2017; 101(9): 1174–1178.
88.
SilvaPSEl-RamiHBarhamR, et al. Hemorrhage and/or microaneurysm severity and count in ultrawide field images and early treatment diabetic retinopathy study photography. Ophthalmology2017; 124(7): 970–976.
89.
WangSZuoYWangN, et al. Fundus fluorescence Angiography in diagnosing diabetic retinopathy. Pak J Med Sci2017; 33(6): 1328–1332.
90.
KimKKimESYuS-Y. Optical coherence tomography angiography analysis of foveal microvascular changes and inner retinal layer thinning in patients with diabetes. Br J Ophthalmol2018; 102(9): 1226–1231.
91.
GuptaCTanRMishraC, et al. Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema—A novel OCT based imaging biomarker. PLoS One. 2018; 13(12): e0207435.
92.
MielerWFMogianesiPWuJ, et al. Biomarkers of diabetic retinopathy based on dynamic fluorescein angiography in control and diabetic patients. Investig Ophthalmol Visual Sci2018; 59(9): 1926.
93.
EhlersJPJiangACBossJD, et al. Quantitative ultra-widefield angiography and diabetic retinopathy severity: an assessment of panretinal leakage index, ischemic index and microaneurysm count. Ophthalmology2019; 126(11): 1527–1532.
94.
Do JeongKParkJYKimBN, et al. Assessment of choroidal thickness inside and outside of vascular arcade in diabetic retinopathy eyes using spectral-domain optical coherence tomography. Sci Rep2019; 9(1): 1–7.
95.
KimKKimESYuS-Y. Progressive retinal neurodegeneration and microvascular change in diabetic retinopathy: longitudinal study using OCT angiography. Acta Diabetologica2019; 56(12): 1275–1282.
96.
AielloLPOdiaIGlassmanAR, et al. Comparison of early treatment diabetic retinopathy study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy. JAMA Ophthalmol2019; 137(1): 65–73.
97.
SilvaPSLiuDGlassmanAR, et al. Assessment of fluorescein angiography nonperfusion in eyes with diabetic retinopathy using ultrawide field retinal imaging. Retina2022; 42(7):1302–1310.
98.
HafnerJPollreiszAEgnerB, et al. Presence of peripheral lesions and correlation to macular perfusion, oxygenation and neurodegeneration in early type II diabetic retinal disease. Retina2020; 40(10): 1964–1971.
99.
SaddaSRNittalaMGTaweebanjongsinW, et al. Quantitative assessment of the severity of diabetic retinopathy. Am J Ophthalmol2020; 218: 342–352.
100.
EndersCBaeuerleFLangGE, et al. Comparison between findings in optical coherence tomography angiography and in fluorescein angiography in patients with diabetic retinopathy. Ophthalmologica2020; 243(1): 21–26.
101.
BuyuktepeTCDemirelSBatıoğluF, et al. The correlation of inflammation and microvascular changes with diabetic retinal neurodegeneration. Curr Eye Res2021; 46(10): 1559–1566.
102.
MuftuogluIKKalraGRasheedMA, et al. Wide-field optical coherence tomography imaging in diabetic retinopathy. Eur J Ophthalmol2021; 32(4): 2298–2305.
103.
AhmedKE-gSIbraheemAMSayedNSM. Comparison between the foveal avascular zone and macular capillary network density in diabetic retinopathy and normal Retina. Egypt J Hospital Med2021; 82(3): 551–557.
104.
ParrulliSCorviFCozziM, et al. Microaneurysms visualisation using five different optical coherence tomography angiography devices compared to fluorescein angiography. Br J Ophthalmol2021;105(4):526–530.
105.
AhmedMAAAbdelhaleemAS. Evaluation of microvascular and visual acuity changes in patients with early diabetic retinopathy: optical coherence tomography angiography study. Clin Ophthalmol2022; 16: 429.
106.
ShirakiASakimotoSEguchiM, et al. Analysis of progressive neovascularization in diabetic retinopathy using widefield OCT angiography. Ophthalmol Retina2022; 6(2): 153–160.
107.
NicoliniNTomboliniBBarresiC, et al. Assessment of diabetic choroidopathy using ultra-widefield optical coherence tomography. Transl Vis Sci Technol2022; 11(3): 35.
